HCA Holdings, Inc. (NYSE:HCA) insider Michael S. Cuffe sold 2,150 shares of HCA Holdings stock in a transaction that occurred on Monday, July 17th. The shares were sold at an average price of $86.44, for a total value of $185,846.00. Following the sale, the insider now owns 12,363 shares in the company, valued at $1,068,657.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Michael S. Cuffe also recently made the following trade(s):

  • On Thursday, June 15th, Michael S. Cuffe sold 2,150 shares of HCA Holdings stock. The shares were sold at an average price of $84.86, for a total value of $182,449.00.

HCA Holdings, Inc. (NYSE HCA) traded down 0.75% during trading on Wednesday, hitting $85.23. The company’s stock had a trading volume of 2,308,870 shares. The company has a 50-day moving average of $85.01 and a 200 day moving average of $84.19. HCA Holdings, Inc. has a one year low of $67.00 and a one year high of $91.03. The firm has a market cap of $31.27 billion, a PE ratio of 11.58 and a beta of 0.69.

HCA Holdings (NYSE:HCA) last announced its earnings results on Tuesday, May 2nd. The company reported $1.74 earnings per share for the quarter, hitting the consensus estimate of $1.74. HCA Holdings had a net margin of 6.70% and a negative return on equity of 45.28%. The business had revenue of $10.62 billion during the quarter, compared to the consensus estimate of $10.64 billion. During the same quarter in the prior year, the firm earned $1.71 earnings per share. The business’s quarterly revenue was up 3.5% compared to the same quarter last year. On average, equities analysts forecast that HCA Holdings, Inc. will post $7.36 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Michael S. Cuffe Sells 2,150 Shares of HCA Holdings, Inc. (NYSE:HCA) Stock” was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another publication, it was stolen and republished in violation of United States & international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2017/07/19/michael-s-cuffe-sells-2150-shares-of-hca-holdings-inc-nysehca-stock.html.

Hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. boosted its position in shares of HCA Holdings by 2,549.4% in the first quarter. BlackRock Inc. now owns 20,099,811 shares of the company’s stock worth $1,788,682,000 after buying an additional 19,341,168 shares during the period. FMR LLC boosted its position in shares of HCA Holdings by 15.8% in the first quarter. FMR LLC now owns 7,763,884 shares of the company’s stock worth $690,908,000 after buying an additional 1,059,925 shares during the period. Old Mutual Global Investors UK Ltd. boosted its position in shares of HCA Holdings by 44.6% in the first quarter. Old Mutual Global Investors UK Ltd. now owns 1,627,311 shares of the company’s stock worth $144,814,000 after buying an additional 501,591 shares during the period. Morgan Stanley boosted its position in shares of HCA Holdings by 51.7% in the first quarter. Morgan Stanley now owns 1,186,998 shares of the company’s stock worth $105,630,000 after buying an additional 404,599 shares during the period. Finally, Vanguard Group Inc. boosted its position in shares of HCA Holdings by 1.9% in the first quarter. Vanguard Group Inc. now owns 19,576,992 shares of the company’s stock worth $1,742,157,000 after buying an additional 361,027 shares during the period. 74.49% of the stock is owned by hedge funds and other institutional investors.

HCA has been the topic of several research reports. Argus initiated coverage on HCA Holdings in a research report on Wednesday, June 28th. They set a “buy” rating and a $100.00 price target on the stock. Zacks Investment Research cut HCA Holdings from a “buy” rating to a “hold” rating in a research note on Tuesday, April 18th. Morgan Stanley started coverage on HCA Holdings in a research note on Tuesday, June 6th. They set an “equal weight” rating and a $90.00 price objective for the company. Mizuho upgraded HCA Holdings from a “neutral” rating to a “buy” rating and set a $98.00 price target for the company in a research note on Monday, March 27th. Finally, BidaskClub upgraded HCA Holdings from a “strong sell” rating to a “sell” rating in a research note on Tuesday, June 13th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and thirteen have given a buy rating to the company’s stock. HCA Holdings has a consensus rating of “Buy” and an average target price of $92.71.

HCA Holdings Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Insider Buying and Selling by Quarter for HCA Holdings (NYSE:HCA)

Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.